COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

201912_Blog_Clinical Services Spotlight_Banner_1768x500_Tricia Heitman.jpg

PCCA's Clinical Services team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a cornerstone of PCCA's abiding desire to provide pharmacies with answers to tough questions. The Clinical Services Spotlight is a limited series of articles designed to highlight a singular member of the Clinical Services team. This third article focuses on Tricia Heitman, PharmD, a woman of high spirit and an indelible joy.

The_Top_5_Blog_Posts_of_2019.png

Thank you to all of our readers and subscribers for supporting the PCCA blog, your support is what makes it the best compounding pharmacy blog online! We’re grateful to be able to produce content that professionals in the pharmacy compounding industry find valuable. With that said, come check out the top five, most valuable PCCA Blog Posts of 2019 that you might have missed!

201912_ThePCCABlog_PIPM_1768x500_v1.jpg

Congratulations to Charles Wall, DPh, owner of Heartland Apothecary located in Knoxville, Tennessee for being our December Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

Tis_the_Season_to_Say_Thank_You_Using_Gratitude_to_Grow_Your_Business.png

Erin Michael, MBA, MS, CPhT, PCCA's Director of Outside Sales wants to let pharmacists know that a little courtesy goes a long, long way when building customer relationships.

201911_Blog_Clinical Services Spotlight_Banner_1768x500.jpg

PCCA's Clinical Services team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a cornerstone of PCCA's abiding desire to provide pharmacies with answers to tough questions. The Clinical Services Spotlight is a limited series of articles designed to highlight a singular member of the Clinical Services team. This second article focuses on Nat Jones, RPh, FIACP, a man who was born to stand in the spotlight.

2Oral_vs_Topical_Estrogen_What_the_Literature_Is_Showing_about_Health_Risk_Part_Two.png

In the first part of this article, Pamela, Nat, and Sara shined a light on new health risk information compounders should consider when providing bioidentical hormone replacement therapy. In this second part of the article, they dive deeper into the BHRT conversation, discussing compounded topical estrogen as an option.

Oral_vs_Topical_Estrogen_What_the_Literature_Is_Showing_about_Health_Risk_Part_One.png

Compounded bioidentical hormone replacement therapy (BHRT) is an important treatment option for women around the world. Colleagues and patients alike come to PCCA experts Pamela Smith, Nat Jones and Sara Hover for guidance. In this article, our three experts cover this all-too-important topic in the HRT conversation, on what current literature says about the usage of oral vs. topical estrogen discussion.

201910_ThePCCABlog_PIPM_1768x500.png

Congratulations to Karen Francis, RPh, owner of Compounding Wellness Pharmacy located in St. John's, Newfoundland and Labrador, Canada for being our November Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

Upcoming_Changes_to_PCCA_Formulas_per_the_New_USP_795_797_and_800_Part_Two.png

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part two in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines. This particular section focuses on USP <797>.

Upcoming_Changes_to_PCCA_Formulas_per_the_New_USP_795_797_and_800_Part_One.png

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part one in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines.